Back to Results
First PageMeta Content
Epidemiology / Nursing research / Drug discovery / Pharmacology / National Institutes of Health / Rare disease / Biomarker / Clinical trial / Orphan drug / Medicine / Health / Science


POLICIES & GUIDELINES Long version April 2013 International Rare Diseases Research Consortium Policies & Guidelines
Add to Reading List

Document Date: 2013-06-10 03:59:07

Open Document

File Size: 727,45 KB

Share Result on Facebook

City

Reykjavik / /

Country

Japan / United States / Iceland / /

Event

Product Issues / /

IndustryTerm

Appropriate clinical management / pharmaceutical industry / therapies for rare diseases / web platform / Model systems / informatics infrastructure / biological systems / diagnostic tools / health care systems / bioinformatics tools / exon-skipping technology / ethical systems / /

MedicalCondition

vascular diseases / nervous system diseases / rare diseases / disease / dysfunction / rare disease / adequate disease / diseases / metabolic disorders / common diseases / /

MedicalTreatment

gene therapy / /

Organization

IRDiRC / European Commission's Health Research Directorate / Council on Orphan Medicinal Products / FDA / Executive Committee / European Union / European Parliament / /

Position

General / /

Product

gene / /

ProgrammingLanguage

EC / /

Technology

gene therapy / bioinformatics / diagnostic tests / exon-skipping technology / network protocols / /

URL

http /

SocialTag